Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 2; peer review: 2 approved]

Background: Lycium barbarum (L. barbarum), popularly referred to as Goji berry, is a promising herb known for its powerful anti-antioxidant, antibacterial, and anti-inflammatory properties. It is used in traditional Chinese medicine for treating inflammatory and infectious diseases. It has also show...

Full description

Bibliographic Details
Main Authors: Shama Prasada Kabekkodu, Usha Nayak, Aditi Chopra, Richard Lobo, Ananth Srivatsa, Divya Adiga, Amee Sanghavi, Ashmeet Shah, Shivaprasada Gadag, Karthik Sivaraman
Format: Article
Language:English
Published: F1000 Research Ltd 2023-02-01
Series:F1000Research
Subjects:
Online Access:https://f1000research.com/articles/11-1563/v2
_version_ 1811170564461559808
author Shama Prasada Kabekkodu
Usha Nayak
Aditi Chopra
Richard Lobo
Ananth Srivatsa
Divya Adiga
Amee Sanghavi
Ashmeet Shah
Shivaprasada Gadag
Karthik Sivaraman
author_facet Shama Prasada Kabekkodu
Usha Nayak
Aditi Chopra
Richard Lobo
Ananth Srivatsa
Divya Adiga
Amee Sanghavi
Ashmeet Shah
Shivaprasada Gadag
Karthik Sivaraman
author_sort Shama Prasada Kabekkodu
collection DOAJ
description Background: Lycium barbarum (L. barbarum), popularly referred to as Goji berry, is a promising herb known for its powerful anti-antioxidant, antibacterial, and anti-inflammatory properties. It is used in traditional Chinese medicine for treating inflammatory and infectious diseases. It has also shown good anti-cancer properties and has been tested against liver, colon, prostate, breast, and cervical cancers. However, no study has yet evaluated the role of goji berries against oral cancer. Hence, the present paper aims to evaluate the anticancer properties of L. barbarum against oral squamous cell carcinoma. Method: Ethanolic extract of L. barbarum (EELB) was tested for its anticancer properties by performing the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, colony formation, cell proliferation, and scratch wound test. The impact of EELB on the signaling transduction pathways of Extracellular signal-regulated kinase (ERK1/2), protein kinase (AKT1), cyclin D1 and epithelial-mesenchymal transition (EMT) was also assessed by western blot. Results: The results showed that EELB can impede CAL-27 cell growth, proliferation and migration in-vitro. It even reduced the phosphorylation of ERK1/2 and AKT1 with concomitant downregulation of cyclin D1 (CCND1), cadherin 2 (CDH2), and vimentin (VIM) and upregulation of cadherin 1 (CDH1) expression suggesting its anti-proliferative and anti-EMT effects in oral cancer. Conclusion: Goji berry has good antiproliferative and anti-invasive properties. It affects potential EMT markers and signaling transduction pathways involved in oral cancers. Hence goji berry can be tried as a potential anticancer agent to manage oral squamous cell carcinoma.
first_indexed 2024-04-10T16:59:49Z
format Article
id doaj.art-980d1588c71e449eacf9538c9e26fafe
institution Directory Open Access Journal
issn 2046-1402
language English
last_indexed 2024-04-10T16:59:49Z
publishDate 2023-02-01
publisher F1000 Research Ltd
record_format Article
series F1000Research
spelling doaj.art-980d1588c71e449eacf9538c9e26fafe2023-02-07T01:00:01ZengF1000 Research LtdF1000Research2046-14022023-02-0111143864Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 2; peer review: 2 approved]Shama Prasada Kabekkodu0Usha Nayak1Aditi Chopra2https://orcid.org/0000-0003-4805-5943Richard Lobo3https://orcid.org/0000-0003-3202-1108Ananth Srivatsa4Divya Adiga5Amee Sanghavi6Ashmeet Shah7Shivaprasada Gadag8Karthik Sivaraman9Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaManipal College of Pharmaceutical Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaManipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaManipal College of Pharmaceutical Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaManipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaManipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaManipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaManipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaManipal College of Pharmaceutical Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaManipal College of Dental Sciences, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, IndiaBackground: Lycium barbarum (L. barbarum), popularly referred to as Goji berry, is a promising herb known for its powerful anti-antioxidant, antibacterial, and anti-inflammatory properties. It is used in traditional Chinese medicine for treating inflammatory and infectious diseases. It has also shown good anti-cancer properties and has been tested against liver, colon, prostate, breast, and cervical cancers. However, no study has yet evaluated the role of goji berries against oral cancer. Hence, the present paper aims to evaluate the anticancer properties of L. barbarum against oral squamous cell carcinoma. Method: Ethanolic extract of L. barbarum (EELB) was tested for its anticancer properties by performing the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, colony formation, cell proliferation, and scratch wound test. The impact of EELB on the signaling transduction pathways of Extracellular signal-regulated kinase (ERK1/2), protein kinase (AKT1), cyclin D1 and epithelial-mesenchymal transition (EMT) was also assessed by western blot. Results: The results showed that EELB can impede CAL-27 cell growth, proliferation and migration in-vitro. It even reduced the phosphorylation of ERK1/2 and AKT1 with concomitant downregulation of cyclin D1 (CCND1), cadherin 2 (CDH2), and vimentin (VIM) and upregulation of cadherin 1 (CDH1) expression suggesting its anti-proliferative and anti-EMT effects in oral cancer. Conclusion: Goji berry has good antiproliferative and anti-invasive properties. It affects potential EMT markers and signaling transduction pathways involved in oral cancers. Hence goji berry can be tried as a potential anticancer agent to manage oral squamous cell carcinoma.https://f1000research.com/articles/11-1563/v2Nutrition Food Fruit Functional food Traditional Chinese Medicine Cancereng
spellingShingle Shama Prasada Kabekkodu
Usha Nayak
Aditi Chopra
Richard Lobo
Ananth Srivatsa
Divya Adiga
Amee Sanghavi
Ashmeet Shah
Shivaprasada Gadag
Karthik Sivaraman
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 2; peer review: 2 approved]
F1000Research
Nutrition
Food
Fruit
Functional food
Traditional Chinese Medicine
Cancer
eng
title Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 2; peer review: 2 approved]
title_full Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 2; peer review: 2 approved]
title_fullStr Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 2; peer review: 2 approved]
title_full_unstemmed Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 2; peer review: 2 approved]
title_short Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study [version 2; peer review: 2 approved]
title_sort goji berry lycium barbarum inhibits the proliferation adhesion and migration of oral cancer cells by inhibiting the erk akt and cyclind cell signaling pathways an in vitro study version 2 peer review 2 approved
topic Nutrition
Food
Fruit
Functional food
Traditional Chinese Medicine
Cancer
eng
url https://f1000research.com/articles/11-1563/v2
work_keys_str_mv AT shamaprasadakabekkodu gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved
AT ushanayak gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved
AT aditichopra gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved
AT richardlobo gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved
AT ananthsrivatsa gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved
AT divyaadiga gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved
AT ameesanghavi gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved
AT ashmeetshah gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved
AT shivaprasadagadag gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved
AT karthiksivaraman gojiberrylyciumbarbaruminhibitstheproliferationadhesionandmigrationoforalcancercellsbyinhibitingtheerkaktandcyclindcellsignalingpathwaysaninvitrostudyversion2peerreview2approved